Pharmaceutical Industry | Page 5 of 10

Browsing: Pharmaceutical Industry

The aspirin mistake: 29 million take it daily, not realizing costs outweigh benefits

By Press Room4 February 2025

Nearly half of survey respondents (48%) incorrectly said that the benefits of taking low-dose aspirin daily to lower one’s odds…

Hims & Hers Super Bowl ad slams pricey pharma industry—and fumbles FDA warnings on compounded GLP-1 drugs

By Press Room3 February 2025

FDA approves Johnson & Johnson’s ketamine-derived nasal spray for depression as standalone treatment

By Press Room23 January 2025

Hate needles? Lilly’s weight-loss pill could get FDA approval next year, CEO says

By Press Room22 January 2025

Eli Lilly & Co., the Fortune 500 pharma firm that manufactures weight-loss injection Zepbound (tirzepatide), has a comparable oral medication…

LVMH dethrones Novo Nordisk as Europe’s most valuable company as Bernard Arnault adds billion to net worth in 2025

LVMH dethrones Novo Nordisk as Europe’s most valuable company as Bernard Arnault adds $12 billion to net worth in 2025

By Press Room20 January 2025

Mark Cuban’s 1K mistake: The Cost Plus Drugs cofounder says CEOs don’t understand health care coverage, and it’s costing them big

Mark Cuban’s $141K mistake: The Cost Plus Drugs cofounder says CEOs don’t understand health care coverage, and it’s costing them big

By Press Room8 January 2025

“Even though health insurance costs are the second-largest line item after payroll, CEOs don’t really understand it or know anything…

Merck-AstraZeneca breast cancer drug reduces risk of death by 28% in patients diagnosed early, clinical trial shows

By Press Room20 December 2024

Lynparza (olaparib), a product of Fortune 500 pharmaceutical firm Merck and Fortune 500 Europe company AstraZeneca, showed meaningful improvements in…

‘I’m not trying to turn GSK into Google’: How GSK’s Silicon Valley veteran has transformed the pharma giant into a tech powerhouse

By Press Room16 December 2024

Most Americans who want to lose weight don’t want to take GLP-1 drugs like Wegovy and Zepbound, new survey says

By Press Room5 December 2024

GLP-1s, or glucagon-like peptide-1 agonist drugs, are seemingly everywhere. In recent years, this class of weight-loss and Type 2 diabetes…

Zepbound vs. Wegovy: New clinical trial says this weight-loss medication sheds more pounds

By Press Room4 December 2024

Amid the war on obesity, a clear winner has emerged in a battle between two weight-loss injectables. Zepbound (tirzepatide), manufactured…

What's On

Clearing Up The Confusion About What Anthropic Really Said On Globally Pausing The Unrelenting Race Toward AI That Builds AI

New Report Claims Apple’s Rumored Foldable Will Only Come In White

How Attenborough’s Film ‘Ocean’ Captured The Scale Of Life At Sea

Browsing: Pharmaceutical Industry

The aspirin mistake: 29 million take it daily, not realizing costs outweigh benefits

Hims & Hers Super Bowl ad slams pricey pharma industry—and fumbles FDA warnings on compounded GLP-1 drugs

FDA approves Johnson & Johnson’s ketamine-derived nasal spray for depression as standalone treatment

Hate needles? Lilly’s weight-loss pill could get FDA approval next year, CEO says

LVMH dethrones Novo Nordisk as Europe’s most valuable company as Bernard Arnault adds $12 billion to net worth in 2025

Mark Cuban’s $141K mistake: The Cost Plus Drugs cofounder says CEOs don’t understand health care coverage, and it’s costing them big

Merck-AstraZeneca breast cancer drug reduces risk of death by 28% in patients diagnosed early, clinical trial shows

‘I’m not trying to turn GSK into Google’: How GSK’s Silicon Valley veteran has transformed the pharma giant into a tech powerhouse

Most Americans who want to lose weight don’t want to take GLP-1 drugs like Wegovy and Zepbound, new survey says

Zepbound vs. Wegovy: New clinical trial says this weight-loss medication sheds more pounds

Unwrap Christmas Sustainably: How To Handle Gifts You Don’t Want

Exclusive: DeFi platform Azura launches after raising $6.9 million from Initialized

Sam Altman’s World Wants To Scan Your Eyes To Prove You’re Human

A Frightening, But Weirdly Bloodless, Episode

Scientists Use AI To Catch Illegal Marine Wildlife Traffickers

Zohran on Trump becoming first sitting president at the NBA Finals: ‘We’re excited to welcome anyone and everyone who’s rooting for the Knicks’

Microsoft Builds Its Own AI Stack To Cut OpenAI Dependence

Our Picks

Clearing Up The Confusion About What Anthropic Really Said On Globally Pausing The Unrelenting Race Toward AI That Builds AI

New Report Claims Apple’s Rumored Foldable Will Only Come In White

How Attenborough’s Film ‘Ocean’ Captured The Scale Of Life At Sea

Most Popular

Top analyst fears bubble popping with investors and Wall Street out over their skis

A Frightening, But Weirdly Bloodless, Episode

Scientists Use AI To Catch Illegal Marine Wildlife Traffickers

Archives

Categories